In conjunction with the court’s order against Teva, AstraZeneca agreed that it too would halt all sales of its authorized generic budesonide inhalation suspension product and take other necessary steps to comply with the court’s decision.
Par is the licensed distributor for AstraZeneca’s authorized generic version of Pulmicort Respules.
The temporary restraining order remains in force until further notice by the court. This action does not effect sales of branded Pulmicort Respules, said Par.